Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$1.4B |
| 2 |
ExxonMobil
XOM
|
+$1.39B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$932M |
| 4 |
Procter & Gamble
PG
|
+$925M |
| 5 |
Walmart Inc
WMT
|
+$834M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$1.66B |
| 2 |
Salesforce
CRM
|
+$1.17B |
| 3 |
Lam Research
LRCX
|
+$974M |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$972M |
| 5 |
Applied Materials
AMAT
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.72% |
| 2 | Financials | 12.27% |
| 3 | Healthcare | 10.07% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Nicolet Bankshares
NIC
$3.62B
| $1.31M | ﹤0.01% |
15,280
-3,060
| -17% | -$244K |
|
652
Wells Fargo
WFC
$264B
| $1.31M | ﹤0.01% |
22,636
+1,736
| +8% | +$90.8K |
|
653
Schwab US Dividend Equity ETF
SCHD
$105B
| $1.29M | ﹤0.01% |
47,823
+9,240
| +24% | +$239K |
|
654
Target
TGT
$68B
| $1.28M | ﹤0.01% |
7,227
-4,334
| -37% | -$659K |
|
655
W&T Offshore
WTI
$518M
| $1.25M | ﹤0.01% |
472,917
-44,328
| -9% | -$127K |
|
656
Vanguard Morningstar Mid-Cap ETF
VO
$109B
| $1.24M | ﹤0.01% |
19,896
+6,348
| +47% | +$375K |
|
657
A10 Networks
ATEN
$1.93B
| $1.24M | ﹤0.01% |
90,641
+20,731
| +30% | +$279K |
|
658
Build-A-Bear
BBW
$462M
| $1.23M | ﹤0.01% |
41,152
| – | – |
|
659
Estee Lauder
EL
$32B
| $1.23M | ﹤0.01% |
7,960
+643
| +9% | +$91.2K |
|
660
State Street SPDR S&P Metals & Mining ETF
XME
$4.42B
| $1.22M | ﹤0.01% |
20,245
+1,804
| +10% | +$103K |
|
661
State Street SPDR Bloomberg International Corporate Bond ETF
IBND
$463M
| $1.21M | ﹤0.01% |
41,478
+13,989
| +51% | +$407K |
|
662
Vanguard Long-Term Treasury ETF
VGLT
$10.1B
| $1.21M | ﹤0.01% |
20,356
-1,240
| -6% | -$73.3K |
|
663
Allient
ALNT
$1.92B
| $1.19M | ﹤0.01% |
33,215
| – | – |
|
664
Casella Waste Systems
CWST
$5.69B
| $1.18M | ﹤0.01% |
11,973
+46
| +0.4% | +$4.12K |
|
665
BioMarin Pharmaceuticals
BMRN
$12.3B
| $1.18M | ﹤0.01% |
13,499
+9
| +0.1% | +$806 |
|
666
MarineMax
HZO
$788M
| $1.17M | ﹤0.01% |
35,148
-3,800
| -10% | -$122K |
|
667
Pricesmart
PSMT
$5.46B
| $1.16M | ﹤0.01% |
13,859
-2,529
| -15% | -$201K |
|
668
NIO
NIO
$11.9B
| $1.16M | ﹤0.01% |
258,495
+13,729
| +6% | +$82.8K |
|
669
Photronics
PLAB
$1.93B
| $1.16M | ﹤0.01% |
41,046
-3,967
| -9% | -$118K |
|
|
DAWN
670
DELISTED
Day One Biopharmaceuticals
DAWN
| $1.13M | ﹤0.01% |
68,411
-35
| -0.1% | -$524 |
|
671
Oil States International
OIS
$491M
| $1.13M | ﹤0.01% |
183,084
| – | – |
|
672
Baidu
BIDU
$37.2B
| $1.13M | ﹤0.01% |
10,700
-313
| -3% | -$33.3K |
|
673
Sutro Biopharma
STRO
$421M
| $1.11M | ﹤0.01% |
19,652
| – | – |
|
674
United Therapeutics
UTHR
$23.1B
| $1.11M | ﹤0.01% |
4,821
+993
| +26% | +$224K |
|
675
Vanguard Morningstar Small-Cap ETF
VB
$82.4B
| $1.1M | ﹤0.01% |
4,833
+3,526
| +270% | +$758K |
|
Similar funds
Ken Fisher's Q1 2024 Portfolio in Review
As of Q1 2024, Ken Fisher held 1,068 positions worth $214B, up 13% from $189B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q1 2024 filing shows 87 new, 392 increased, 448 reduced and 104 closed positions. Its largest new stake was Nomura Holdings: 8,478,338 shares worth $54.4M. The largest sale was ASML, an estimated $1.66B.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q1 2024 buy was Nomura Holdings: 8,478,338 shares worth $54.4M.
- Ken Fisher added most to Chevron in Q1 2024, an estimated $1.4B increase.
- Ken Fisher's biggest Q1 2024 reduction was ASML, cutting an estimated $1.66B.
- Ken Fisher fully exited Veradigm Inc. Common Stock in Q1 2024, selling an estimated $23.8M.
- Ken Fisher's ten largest holdings make up 31% of its $214B portfolio in Q1 2024.
- Ken Fisher opened 87 new positions and closed 104 in Q1 2024.
- Ken Fisher's portfolio value rose 13% quarter-over-quarter to $214B.
Based on Fisher Asset Management's 13F filing for Q1 2024, filed 9 May 2024.